We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Yourgene to process tests at lab as part of MyHealthChecked Boots deal

Mon, 22nd May 2023 14:26

(Alliance News) - Yourgene Health PLC on Monday said that is due to process diagnostic tests at its laboratory in Manchester, as part of a deal signed by its partner, MyHealthChecked PLC, with Boots UK Ltd.

Yourgene is a Manchester, England-based molecular diagnostic group, while MyHealthChecked is a consumer home-testing healthcare company.

Last Friday, MyHealthChecked PLC said it had signed an agreement via its subsidiary, Concepta Diagnostics Ltd, to launch its extended range of products with Boots UK.

Yourgene told investors on Monday that, according to the service agreement, five out of the 14 tests that MyHealthChecked are launching via Boots will be processed by Yourgene Genomic Services at its accredited laboratory in Manchester.

"We would like to congratulate our partner MyHealthChecked on their retail launch with Boots of their extended product portfolio, which demonstrates execution of the next step of their strategic plan. Yourgene is proud to continue to support MyHealthChecked with our state-of-the-art laboratory and the contract is a testament to the quality of the service we provide," said Chief Executive Office Lyn Rees.

Separately, Yourgene said it has reappointed Chief Scientific Officer Joanne Mason as a director of the company with immediate effect.

"Given Dr Mason's background and experience in this field, she is playing an increasingly pivotal role for the company in highlighting the technical benefits of the company's offerings to potential and existing customers, and her expertise provides an important complement to the skills and understanding of the wider board," Yourgene said.

Yourgene shares were trading 1.8% higher at 0.21 pence each in London on Monday afternoon.

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
8 Sep 2023 11:58

Novacyt completes buy of molecular diagnostics firm Yourgene Health

(Alliance News) - Yourgene Health PLC on Friday announced that its takeover by Novacyt SA, a biotechnology group focused on clinical diagnostics, is c...

7 Sep 2023 20:27

TRADING UPDATES: Tintra receives bid approach; NCC trading in line

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

1 Sep 2023 21:59

Yourgene, Pathfinder, Spectral MD and Finncap to be deleted on AIM

(Alliance News) - FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series.

17 Aug 2023 19:46

IN BRIEF: Novacyt takeover of Yourgene Health closer to completion

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by...

10 Aug 2023 15:46

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.